市場調查報告書

全球肌肉鬆弛劑市場:2020-2026

Global Muscle Relaxant Drug Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949492
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球肌肉鬆弛劑市場:2020-2026 Global Muscle Relaxant Drug Market 2020-2026
出版日期: 2020年06月01日內容資訊: 英文
簡介

預計在預測期內,全球肌肉鬆弛劑市場將顯著增長。全球肌肉鬆弛劑市場增長的主要驅動力是易受肌肉骨骼疾病困擾的老年人數量的增加,這導致肌肉鬆弛劑的採用在預測期內有所增加。正在推動市場的增長。此外,在預測期內,由於可獲得藥物引起的人們疼痛症狀的日益流行正在推動市場增長。但是,與藥物相關的某些副作用可能會阻礙市場的增長。

全球肌肉鬆弛劑市場根據產品類型和配方細分。按產品類型劃分,全球肌肉鬆弛劑市場分為外周肌肉鬆弛劑,面部美容鬆弛劑和中樞肌肉鬆弛劑。在預測期內,周圍肌肉鬆弛劑市場佔有很大份額。按產品劃分,市場分為口服和注射產品。口語部分可能會佔據最大的市場份額。

從地理上講,全球肌肉鬆弛劑市場報告包括北美(美國和加拿大),歐洲(英國,德國,意大利,西班牙,法國,其他國家),亞太地區(中國,日本,印度等)。 ,涵蓋了世界其他四個地區。在預測期內,亞太地區估計將在全球肌肉鬆弛劑市場中顯示出顯著增長。該地區日益老齡化的人口正在推動市場增長。此外,改善醫療基礎設施將進一步支持區域市場增長。

該報告調查了全球肌肉鬆弛劑市場,提供了市場概況,按產品類型,配方和地區劃分的趨勢以及進入該市場的公司的概況。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 主要策略分析
  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的進展

第4章市場決定因素

  • 動機
  • 抑制因子
  • 市場機會

第5章市場細分

  • 按產品類型分列的全球肌肉放鬆劑市場
    • 周圍肌肉鬆弛劑
    • 面部美容鬆弛劑
    • 中樞肌肉鬆弛劑
  • 按產品分列的全球肌肉放鬆劑市場
    • 口頭代理
    • 注射

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Aurobindo Pharma Ltd.
  • Cadila Healthcare Ltd.
  • DBL Pharma Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc.
  • Ipsen Biopharmaceuticals Inc.
  • Johnson & Johnson Services Inc.
  • Merck & Co. Inc.
  • Mylan NV
  • Neurana Pharmaceuticals
  • Novartis International AG
  • Orient Pharma Co. Ltd.
  • Par Pharmaceutical Inc.
  • Pfizer Inc.
  • Vertical Pharmaceuticals LLC
目錄
Product Code: OMR2021811

Global Muscle Relaxant Drug Market Size, Share & Trends Analysis Report by Product Type (Peripherally Acting Muscle Relaxants, Facial Aesthetic Relaxants, and Centrally Acting Muscle Relaxants), By Formulation (Oral and Injectable) Forecast, 2020-2026

The global muscle relaxant drug market is projected to grow significantly during the forecast period. The primary factors that are driving the growth of the global muscle relaxant drug industry include the increased number of geriatric populations who are more prone to musculoskeletal disorders which in turn enhances the adoption of muscle relaxant drugs and thereby fuel the market growth during the forecast period. Further, the rising prevalence of pain conditions in the peoples along with the availability of drugs is propelling the growth of the market during the forecast period. However, some side effects associated with the drugs may challenge the growth of the market.

The global muscle relaxant drug market is segmented on the basis of product type and formulation. Based on the product type, the global muscle relaxant drug industry is segmented into peripherally acting muscle relaxants, facial aesthetic relaxants, and centrally acting muscle relaxants. Peripherally acting muscle relaxants segment holds a significant share in the market over the forecast period. Based on the formulation, the market is bifurcated into oral and injectable. The oral segment is likely to hold the most significant share in the market.

Geographically, the study of the global muscle relaxant drug market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global muscle relaxant drug market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Further, AbbVie Inc., Acorda Therapeutics Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Mylan NV, Orient Pharma Co. Ltd., Par Pharmaceutical Inc., and Pfizer Inc. are some of the prominent players operating in the global muscle relaxant drug market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market.

Research Methodology

The market study of the global muscle relaxant drug market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for muscle relaxant drug market players, drug manufacturing companies, investment companies, industry associations & experts, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Muscle Relaxant Drug Market Research and Analysis by Type

2. Global Muscle Relaxant Drug Market Research and Analysis by Route of Administration

The Report Covers:

  • Comprehensive research methodology of the global muscle relaxant drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global muscle relaxant drug market.
  • Insights about market determinants which are stimulating the global muscle relaxant drug market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Muscle Relaxant Drug Market by Product Type
    • 5.1.1. Peripherally Acting Muscle Relaxants
    • 5.1.2. Facial Aesthetic Relaxants
    • 5.1.3. Centrally Acting Muscle Relaxants
  • 5.2. Global Muscle Relaxant Drug Market by Formulation
    • 5.2.1. Oral
    • 5.2.2. Injectable

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AbbVie Inc.
  • 7.2. Acorda Therapeutics Inc.
  • 7.3. Aurobindo Pharma Ltd.
  • 7.4. Cadila Healthcare Ltd.
  • 7.5. DBL Pharma Inc.
  • 7.6. Dr. Reddy's Laboratories Ltd.
  • 7.7. Endo Pharmaceuticals Inc.
  • 7.8. Ipsen Biopharmaceuticals Inc.
  • 7.9. Johnson & Johnson Services Inc.
  • 7.10. Merck & Co. Inc.
  • 7.11. Mylan NV
  • 7.12. Neurana Pharmaceuticals
  • 7.13. Novartis International AG
  • 7.14. Orient Pharma Co. Ltd.
  • 7.15. Par Pharmaceutical Inc.
  • 7.16. Pfizer Inc.
  • 7.17. Vertical Pharmaceuticals LLC

LIST OF TABLES

  • 1. GLOBAL MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL PERIPHERALLY ACTING MUSCLE RELAXANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL FACIAL AESTHETIC RELAXANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL CENTRALLY ACTING MUSCLE RELAXANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY FORMULATION, 2019-2026 ($ MILLION)
  • 6. GLOBAL ORAL MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL INJECTABLE MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 9. NORTH AMERICAN MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 10. NORTH AMERICAN MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2019-2026 ($ MILLION)
  • 11. NORTH AMERICAN MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY FORMULATION, 2019-2026 ($ MILLION)
  • 12. EUROPEAN MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 13. EUROPEAN MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2019-2026 ($ MILLION)
  • 14. EUROPEAN MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY FORMULATION, 2019-2026 ($ MILLION)
  • 15. ASIA-PACIFIC MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 16. ASIA-PACIFIC MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2019-2026 ($ MILLION)
  • 17. ASIA-PACIFIC MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY FORMULATION, 2019-2026 ($ MILLION)
  • 18. REST OF THE WORLD MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2019-2026 ($ MILLION)
  • 19. REST OF THE WORLD MUSCLE RELAXANT DRUG MARKET RESEARCH AND ANALYSIS BY FORMULATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MUSCLE RELAXANT DRUG MARKET SHARE BY PRODUCT TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL MUSCLE RELAXANT DRUG MARKET SHARE BY FORMULATION, 2019 VS 2026 (%)
  • 3. GLOBAL MUSCLE RELAXANT DRUG MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD MUSCLE RELAXANT DRUG MARKET SIZE, 2019-2026 ($ MILLION)